{"entity":{"type":"insider","cik":"0001813800","url":"/insider/0001813800","json_url":"/insider/0001813800.json","name":"Fairman Jeff","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":20,"first":"2021-01-28","last":"2022-10-28","span_basis":"filed_date"},"name_variants":[{"name":"Fairman Jeff","source":"filing","n_filings":20,"first_seen":"2021-01-28","last_seen":"2022-10-28"}],"transactions":[{"id":6632133,"accession":"0001209191-22-054858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054858","line_url":"/filing/0001209191-22-054858#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":286227.0,"shares_owned_after_display":"286,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6331145,"accession":"0001209191-22-053579","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053579","line_url":"/filing/0001209191-22-053579#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":127500.0,"total_display":"127,500.00","total_whole":"127,500","shares_owned_after":296227.0,"shares_owned_after_display":"296,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-13","scope":"insider"},{"id":6305716,"accession":"0001209191-22-049025","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-049025","line_url":"/filing/0001209191-22-049025","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":26.57842672,"price_display":"26.58","price_state":"stated","total_value":132892.1336,"total_display":"132,892.13","total_whole":"132,892","shares_owned_after":301563.0,"shares_owned_after_display":"301,563","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-07","scope":"insider","n_lines":2},{"id":6893073,"accession":"0001209191-22-044659","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044659","line_url":"/filing/0001209191-22-044659#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.7015,"price_display":"25.70","price_state":"stated","total_value":128507.5,"total_display":"128,507.50","total_whole":"128,508","shares_owned_after":306227.0,"shares_owned_after_display":"306,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-05","filed_date":"2022-08-05","scope":"insider"},{"id":6893067,"accession":"0001209191-22-044659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044659","line_url":"/filing/0001209191-22-044659#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":255000.0,"total_display":"255,000.00","total_whole":"255,000","shares_owned_after":311227.0,"shares_owned_after_display":"311,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6851996,"accession":"0001209191-22-031619","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-031619","line_url":"/filing/0001209191-22-031619#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4112.0,"shares_display":"4,112","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":104856.0,"total_display":"104,856.00","total_whole":"104,856","shares_owned_after":321227.0,"shares_owned_after_display":"321,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-24","scope":"insider"},{"id":6251169,"accession":"0001209191-22-027848","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-027848","line_url":"/filing/0001209191-22-027848#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":888.0,"shares_display":"888","price_per_share":25.8045,"price_display":"25.80","price_state":"stated","total_value":22914.396,"total_display":"22,914.40","total_whole":"22,914","shares_owned_after":325339.0,"shares_owned_after_display":"325,339","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-05","filed_date":"2022-05-09","scope":"insider"},{"id":6147713,"accession":"0001209191-22-023695","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023695","line_url":"/filing/0001209191-22-023695#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.59,"price_display":"25.59","price_state":"stated","total_value":127950.0,"total_display":"127,950.00","total_whole":"127,950","shares_owned_after":326227.0,"shares_owned_after_display":"326,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-05","filed_date":"2022-04-07","scope":"insider"},{"id":6295456,"accession":"0001209191-22-019027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-019027","line_url":"/filing/0001209191-22-019027#line-1","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.5,"price_display":"25.50","price_state":"stated","total_value":255000.0,"total_display":"255,000.00","total_whole":"255,000","shares_owned_after":331227.0,"shares_owned_after_display":"331,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":5262379,"accession":"0001209191-21-071376","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-071376","line_url":"/filing/0001209191-21-071376","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":23.59842105263158,"price_display":"23.60","price_state":"stated","total_value":112092.5,"total_display":"112,092.50","total_whole":"112,093","shares_owned_after":6335.0,"shares_owned_after_display":"6,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-27","filed_date":"2021-12-28","scope":"insider","n_lines":2},{"id":4849753,"accession":"0001209191-21-070572","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-070572","line_url":"/filing/0001209191-21-070572#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4619.0,"shares_display":"4,619","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":103927.5,"total_display":"103,927.50","total_whole":"103,928","shares_owned_after":6160.0,"shares_owned_after_display":"6,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-16","filed_date":"2021-12-20","scope":"insider"},{"id":4958470,"accession":"0001209191-21-069292","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-069292","line_url":"/filing/0001209191-21-069292#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":2947.5,"total_display":"2,947.50","total_whole":"2,948","shares_owned_after":6160.0,"shares_owned_after_display":"6,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-13","scope":"insider"},{"id":4587689,"accession":"0001209191-21-061940","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-061940","line_url":"/filing/0001209191-21-061940#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":22.69,"price_display":"22.69","price_state":"stated","total_value":107777.5,"total_display":"107,777.50","total_whole":"107,778","shares_owned_after":5144.0,"shares_owned_after_display":"5,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4343324,"accession":"0001209191-21-058125","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-058125","line_url":"/filing/0001209191-21-058125","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":26.169071578947367,"price_display":"26.17","price_state":"stated","total_value":124303.09,"total_display":"124,303.09","total_whole":"124,303","shares_owned_after":5283.0,"shares_owned_after_display":"5,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-27","filed_date":"2021-09-29","scope":"insider","n_lines":2},{"id":4182968,"accession":"0001209191-21-053901","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-053901","line_url":"/filing/0001209191-21-053901","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":25.377473684210525,"price_display":"25.38","price_state":"stated","total_value":120543.0,"total_display":"120,543.00","total_whole":"120,543","shares_owned_after":5144.0,"shares_owned_after_display":"5,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-30","scope":"insider","n_lines":2},{"id":4340855,"accession":"0001209191-21-048429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-048429","line_url":"/filing/0001209191-21-048429#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":22.7,"price_display":"22.70","price_state":"stated","total_value":107825.0,"total_display":"107,825.00","total_whole":"107,825","shares_owned_after":5144.0,"shares_owned_after_display":"5,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-26","filed_date":"2021-07-28","scope":"insider"},{"id":4622611,"accession":"0001209191-21-044018","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-044018","line_url":"/filing/0001209191-21-044018","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":24.372597894736842,"price_display":"24.37","price_state":"stated","total_value":115769.84,"total_display":"115,769.84","total_whole":"115,770","shares_owned_after":5280.0,"shares_owned_after_display":"5,280","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider","n_lines":2},{"id":4339071,"accession":"0001209191-21-039204","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-039204","line_url":"/filing/0001209191-21-039204#line-3","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9500.0,"shares_display":"9,500","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":213750.0,"total_display":"213,750.00","total_whole":"213,750","shares_owned_after":5144.0,"shares_owned_after_display":"5,144","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-07","filed_date":"2021-06-09","scope":"insider"},{"id":4138767,"accession":"0001209191-21-023482","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-023482","line_url":"/filing/0001209191-21-023482","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":23.88068210526316,"price_display":"23.88","price_state":"stated","total_value":113433.24,"total_display":"113,433.24","total_whole":"113,433","shares_owned_after":2769.0,"shares_owned_after_display":"2,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-26","filed_date":"2021-03-29","scope":"insider","n_lines":2},{"id":5146158,"accession":"0001209191-21-016339","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-016339","line_url":"/filing/0001209191-21-016339","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":23.92909894736842,"price_display":"23.93","price_state":"stated","total_value":113663.22,"total_display":"113,663.22","total_whole":"113,663","shares_owned_after":2848.0,"shares_owned_after_display":"2,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-02","scope":"insider","n_lines":3},{"id":4881599,"accession":"0001209191-21-005892","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-005892","line_url":"/filing/0001209191-21-005892","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001813800","owner_name":"Fairman Jeff","owner_display_name":"Fairman Jeff","owner_url":"/insider/0001813800","role":"Officer (VP, Research)","role_mark":"O","role_mark_label":"Officer (VP, Research)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP, Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4750.0,"shares_display":"4,750","price_per_share":25.26621052631579,"price_display":"25.27","price_state":"stated","total_value":120014.5,"total_display":"120,014.50","total_whole":"120,015","shares_owned_after":1833.0,"shares_owned_after_display":"1,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-26","filed_date":"2021-01-28","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Officer (VP, Research)","n_filings":20,"first_seen":"2021-01-28","last_seen":"2022-10-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001813800","retrieved_at":"2026-08-27T09:37:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}